Gray J M, Silberman H M, Gorwit J I
Escondido Cardiology Associates, California.
Am J Med. 1988 May;84(5):904-10. doi: 10.1016/0002-9343(88)90070-8.
The differential effects of prazosin and labetalol on blood pressure and heart rate in the clinic and during daily activity were measured in a double-blind study utilizing automatic ambulatory monitors. One hundred five patients with essential hypertension (sitting diastolic blood pressure equal to 101 mm Hg) were randomly assigned to receive prazosin (n = 52) or labetalol (n = 53). Sixty-eight percent of labetalol-treated patients and 50 percent of prazosin-treated patients achieved blood pressure control during clinic visits (sitting diastolic blood pressure less than 90 mm Hg) and were subsequently monitored for 12 hours of normal daily activities. Ambulatory monitoring revealed labetalol-treated patients to have significantly greater decreases in systolic and diastolic blood pressures during daily activity than prazosin-treated patients. Heart rate and rate-pressure product were significantly reduced in the labetalol group but not in the prazosin group. It is concluded that the potential benefits of dual adrenergic blockade, not readily apparent in the non-stressful clinic environment, become more evident during the course of daily activities.
在一项使用自动动态监测仪的双盲研究中,测量了哌唑嗪和拉贝洛尔在临床及日常活动期间对血压和心率的不同影响。105例原发性高血压患者(坐位舒张压等于101 mmHg)被随机分配接受哌唑嗪(n = 52)或拉贝洛尔(n = 53)治疗。在门诊就诊期间,68%接受拉贝洛尔治疗的患者和50%接受哌唑嗪治疗的患者实现了血压控制(坐位舒张压低于90 mmHg),随后对他们正常日常活动的12小时进行了监测。动态监测显示,与接受哌唑嗪治疗的患者相比,接受拉贝洛尔治疗的患者在日常活动期间收缩压和舒张压的下降幅度明显更大。拉贝洛尔组的心率和心率-血压乘积显著降低,但哌唑嗪组未降低。得出的结论是,双重肾上腺素能阻断的潜在益处,在无压力的临床环境中并不明显,而在日常活动过程中变得更加明显。